ATLANTA (Reuters) - Brain cancer is now the deadliest form of childhood cancer in the United States, surpassing leukemia as treatment advances have allowed doctors to cure many blood-related cancers, the Centers for Disease Control and Prevention said on Friday.

(Reuters) - U.S. drugmaker Pfizer Inc's breast cancer drug, Ibrance, should be given marketing approval, an advisory committee at the European Medicines Agency recommended.

NEW YORK, Sept 16 (Reuters) - General Electric Co said it will receive $1.9 billion for a contract to supply steam turbines, generators and other equipment to the Hinkley Point C project, the United Kingdom's first new nuclear power plant in decades.

FRANKFURT (Reuters) - AstraZeneca said combining its Forxiga type-2 diabetes drug with older medicine Bydureon was more effective at controlling blood sugar levels than treatment with either drug on its own.

BERLIN (Reuters) - Volkswagen's ability to agree a big cost-cutting plan with its powerful labor unions in the coming weeks could determine whether the German carmaker's shares make a full recovery from its emissions scandal.

COPENHAGEN (Reuters) - Novo Nordisk's experimental injectable diabetes drug semaglutide reduced cardiovascular risk by 26 percent, according to results released on Friday, paving the way for a new and bigger study on the drug's benefits.

TOKYO, Sept 16 (Reuters) - The stabbing deaths of 19 disabled people in their sleep last July and the silence surrounding their identities are forcing Japan to grapple with its attitudes toward physically and cognitively impaired persons, less than four years before Tokyo hosts the Paralympics.

BENGALURU, Sept 16 (Reuters) - Oracle employees were at work on Monday when protesters entered their nine-story building in India's technology hub, Bengaluru, and asked them to leave in support of demonstrations that had erupted across the city over a water dispute.

SAN FRANCISCO (Thomson Reuters Foundation) - Greater support from the public, governments and investors is needed to boost the work of entrepreneurs using business for social good, said industry activists and organizers after a Thomson Reuters Foundation poll highlighted these as key issues.